Bottneuro AG
Providing digital diagnostic solutions and non-invasive treatments for alzheimer’s disease.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | CHF4.0m | Seed | |
| Total Funding | 000k | ||
Related Content
Bottneuro is a Swiss-based startup focused on revolutionizing the diagnosis and treatment of neurological diseases, particularly Alzheimer's Disease (AD), through advanced technology. The company leverages digital biomarkers, brain imaging, and neuromodulation technologies to create personalized treatment devices. Their flagship product is a patient-specific transcranial electrical stimulation (tES) device. This device is designed for non-invasive, multifocal electrical stimulation of specific brain regions at predefined frequencies, which helps in targeting and treating neurological conditions more effectively.
Bottneuro primarily serves patients suffering from neurodegenerative diseases, with a strong focus on Alzheimer's Disease. The company operates in the healthcare and biotechnology market, which is rapidly growing due to increasing awareness and the prevalence of neurological disorders.
The business model of Bottneuro is centered around the development, manufacturing, and sale of custom-made medical devices. They generate revenue by selling these specialized tES devices to healthcare providers, clinics, and directly to patients. Additionally, Bottneuro collaborates with other companies and research institutions to enhance their diagnostic and treatment capabilities, which may also contribute to their revenue through partnerships and joint ventures.
Bottneuro's approach is highly personalized, ensuring that each device is tailored to the specific needs of the patient. This customization is based on detailed brain imaging and the use of digital biomarkers, which are indicators found in digital data that can signify the presence of a disease. By focusing on personalized therapy, Bottneuro aims to bring sustainable improvements to patients' lives and slow down the progression of neurodegenerative diseases.
In summary, Bottneuro is at the forefront of personalized neurological treatment, combining cutting-edge technology with a patient-centric approach to improve outcomes for those suffering from debilitating brain diseases.
Keywords: Neurological, Alzheimer's, tES device, brain imaging, digital biomarkers, neuromodulation, personalized therapy, non-invasive, healthcare, biotechnology.